Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220961644> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4220961644 endingPage "100258" @default.
- W4220961644 startingPage "100258" @default.
- W4220961644 abstract "This study aimed to identify the pharmacological targets and mechanisms of action of the traditional Indian plant, Saraca asoca bioactive, gallic acid, in the treatment of cataract using bioinformatics tools i.e., network pharmacology. Targets of cataract were obtained by using DisGeNET gene discovery web-based database. The herbal ingredients target (HIT), the SuperPred, and the SwissTargetPrediction database were used for compound target prediction i.e., targets of gallic acid. Pathophysiological and therapeutic targets were imported to the STRING database, and the Cytoscape network integration software was used to construct component-target and disease-target interaction networks as a part of protein-protein interaction (PPI). Core targets were identified by network topological parameters and were further tested to identify the biological process and the signaling pathways by using functional enrichment analysis tool, FunRich. Key targets genes for gallic acid in the treatment of patients with cataract were identified, including indoleamine-2,3-dioxygenase-1 (IDO1), serum albumin (ALB), estrogen receptor (ESR1), prostaglandin G/H synthase-2 (PTGS2), epidermal growth factor receptor (EGFR), plasminogen activator inhibitor-1 (SERPINE1), aromatase (CYP19A1), neutrophil elastase (ELANE), and catechol-O-methyltransferase (COMT), apoptosis regulator (BCL2), carbonic anhydrase-4 (CA4), tyrosine-protein kinase receptor UFO (AXL), tyrosinase (TYR), kallikrein-7 (KLK7), and serine/threonine-protein kinase (NEK2). The signaling pathways of core targets mainly involved signaling events mediated by BMP receptors, integrins, proteoglycan syndecan, glypican, TRAIL, S1P (sphingosine-1-phosphate), LKB1, endothelins, VEGF, VEGFR, estrogen receptors, INF-γ, IL-5, mTOR, biological oxidation, kynurenines formation, TGF-β, etc. Pharmacological network analysis was used to identify the gene targets and mechanisms of gallic acid for the treatment of patient with cataract." @default.
- W4220961644 created "2022-04-03" @default.
- W4220961644 creator A5046341196 @default.
- W4220961644 creator A5068637399 @default.
- W4220961644 creator A5087570825 @default.
- W4220961644 date "2022-05-01" @default.
- W4220961644 modified "2023-09-30" @default.
- W4220961644 title "Pharmacological target and the biological mechanism of gallic acid for anticataract effect: A network analysis" @default.
- W4220961644 cites W1536445869 @default.
- W4220961644 cites W1977982633 @default.
- W4220961644 cites W1981201913 @default.
- W4220961644 cites W1986765223 @default.
- W4220961644 cites W2047341144 @default.
- W4220961644 cites W2073783249 @default.
- W4220961644 cites W2075713021 @default.
- W4220961644 cites W2082031952 @default.
- W4220961644 cites W2107530732 @default.
- W4220961644 cites W2124557419 @default.
- W4220961644 cites W2548936120 @default.
- W4220961644 cites W2561225154 @default.
- W4220961644 cites W2749992805 @default.
- W4220961644 cites W2902330400 @default.
- W4220961644 cites W2912193604 @default.
- W4220961644 cites W2950399478 @default.
- W4220961644 cites W2951329663 @default.
- W4220961644 cites W2976384185 @default.
- W4220961644 cites W2991087990 @default.
- W4220961644 cites W3010606272 @default.
- W4220961644 cites W3045873975 @default.
- W4220961644 cites W3110648523 @default.
- W4220961644 cites W4211201440 @default.
- W4220961644 cites W4253167256 @default.
- W4220961644 cites W1971730827 @default.
- W4220961644 doi "https://doi.org/10.1016/j.phyplu.2022.100258" @default.
- W4220961644 hasPublicationYear "2022" @default.
- W4220961644 type Work @default.
- W4220961644 citedByCount "3" @default.
- W4220961644 countsByYear W42209616442022 @default.
- W4220961644 countsByYear W42209616442023 @default.
- W4220961644 crossrefType "journal-article" @default.
- W4220961644 hasAuthorship W4220961644A5046341196 @default.
- W4220961644 hasAuthorship W4220961644A5068637399 @default.
- W4220961644 hasAuthorship W4220961644A5087570825 @default.
- W4220961644 hasBestOaLocation W42209616441 @default.
- W4220961644 hasConcept C2778004101 @default.
- W4220961644 hasConcept C2778362808 @default.
- W4220961644 hasConcept C55493867 @default.
- W4220961644 hasConcept C62478195 @default.
- W4220961644 hasConcept C86803240 @default.
- W4220961644 hasConcept C98274493 @default.
- W4220961644 hasConceptScore W4220961644C2778004101 @default.
- W4220961644 hasConceptScore W4220961644C2778362808 @default.
- W4220961644 hasConceptScore W4220961644C55493867 @default.
- W4220961644 hasConceptScore W4220961644C62478195 @default.
- W4220961644 hasConceptScore W4220961644C86803240 @default.
- W4220961644 hasConceptScore W4220961644C98274493 @default.
- W4220961644 hasIssue "2" @default.
- W4220961644 hasLocation W42209616441 @default.
- W4220961644 hasOpenAccess W4220961644 @default.
- W4220961644 hasPrimaryLocation W42209616441 @default.
- W4220961644 hasRelatedWork W2011110130 @default.
- W4220961644 hasRelatedWork W2066719106 @default.
- W4220961644 hasRelatedWork W2391636262 @default.
- W4220961644 hasRelatedWork W2553714240 @default.
- W4220961644 hasRelatedWork W2600689296 @default.
- W4220961644 hasRelatedWork W2604934725 @default.
- W4220961644 hasRelatedWork W2795031019 @default.
- W4220961644 hasRelatedWork W3121580697 @default.
- W4220961644 hasRelatedWork W4312084407 @default.
- W4220961644 hasRelatedWork W2738627170 @default.
- W4220961644 hasVolume "2" @default.
- W4220961644 isParatext "false" @default.
- W4220961644 isRetracted "false" @default.
- W4220961644 workType "article" @default.